In its second major partnership with a big pharma group, UK-based AI and multi-omics company Relation Therapeutics has agreed to seek out targets for allergic diseases on behalf of Novartis. The ...

Novartis has tapped up an artificial-intelligence-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions. What caught the Swiss pharma’s eye ...

Bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) is a ubiquitous bacterial second-messenger molecule that is involved in the molecular decision between planktonic motile and sedentary ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Since the launch of the Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced the Mini Crossword — followed by Spelling Bee, Letter ...

Discover how drip marketing engages prospects over time using email, social media, and direct mail. Learn strategies to keep ...

Rebecca Lissner, senior fellow for U.S. foreign policy at the Council, sits down with James M. Lindsay to discuss the Trump administration's new National Security Strategy and its consequences for U.S ...

The writer extols the virtues of immersing oneself in nature and laments the inevitable encroachment of private ownership upon the wilderness. I wish to speak a word for Nature, for absolute freedom ...

The future of defense strategy requires restructuring forces for modern threats, focusing deployments on critical regions, accelerating tech integration, reforming procurement and budgets, ...